Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Nutr ; 108(7): 1235-45, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22172428

ABSTRACT

In the elderly, immunosenescence and malnourishment can contribute to increased risk and severity of upper respiratory tract infections (URTI). Gold kiwifruit (Actinidia chinensis 'Hort16A') contains nutrients important for immune function and mitigation of symptoms of infection, including vitamins C and E, folate, polyphenols and carotenoids. The objective of the present study was to evaluate whether regular consumption of gold kiwifruit reduces symptoms of URTI in older people, and determine the effect it has on plasma antioxidants, and markers of oxidative stress, inflammation and immune function. A total of thirty-two community-dwelling people (≥65 years) participated in a randomised crossover study, consuming the equivalent of four kiwifruit or two bananas daily for 4 weeks, with treatments separated by a 4-week washout period. Participants completed the Wisconsin Upper Respiratory Symptom Survey-21 daily, and blood samples were collected at baseline and at the end of each treatment and washout period. Gold kiwifruit did not significantly reduce the overall incidence of URTI compared with banana, but significantly reduced the severity and duration of head congestion, and the duration of sore throat. Gold kiwifruit significantly increased plasma vitamin C, α-tocopherol and lutein/zeaxanthin concentrations, and erythrocyte folate concentrations, and significantly reduced plasma lipid peroxidation. No changes to innate immune function (natural killer cell activity, phagocytosis) or inflammation markers (high-sensitivity C-reactive protein, homocysteine) were detected. Consumption of gold kiwifruit enhanced the concentrations of several dietary plasma analytes, which may contribute to reduced duration and severity of selected URTI symptoms, offering a novel tool for reducing the burden of URTI in older individuals.


Subject(s)
Actinidia , Aging/immunology , Ascorbic Acid/blood , Fruit , Immunity, Innate , Respiratory Tract Infections/blood , Respiratory Tract Infections/prevention & control , Aged , Antioxidants/analysis , Biomarkers/blood , Cross-Over Studies , Erythrocytes/metabolism , Female , Folic Acid/blood , Humans , Incidence , Lipid Peroxidation , Male , New Zealand/epidemiology , Oxidative Stress , Pigmentation , Pilot Projects , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/physiopathology , Severity of Illness Index
2.
J Nat Prod ; 73(4): 743-6, 2010 Apr 23.
Article in English | MEDLINE | ID: mdl-20297825

ABSTRACT

Bioactivity-guided fractionation of an ethanolic extract of the rhizome of Pleuranthodium racemigerum, a tropical Zingiberaceae species from Northeastern Australia, resulted in the isolation and structural elucidation of 1-(4''-methoxyphenyl)-7-(4'-hydroxyphenyl)-(E)-hept-2-ene (1), a new diarylheptanoid related to curcumin. Compound 1 was a fairly potent inhibitor of prostaglandin E(2) production in 3T3 murine fibroblasts (IC(50) approximately 34 microM) and also displayed moderate cytotoxicity against this cell line (IC(50) = 52.8 microM). The compound also demonstrated cytotoxic activity against the P388D1 murine lymphoblast cell line (IC(50) = 117.0 microM) and four human cell lines: Caco-2 colonic adenocarcinoma (IC(50) = 44.8 microM), PC3 prostate adenocarcinoma (IC(50) = 23.6 microM), HepG2 hepatocyte carcinoma (IC(50) = 40.6 microM), and MCF7 mammary adenocarcinoma (IC(50) = 56.9 microM). The cytotoxicity of compound 1 closely resembled that of curcumin, in terms of both IC(50) values and dose-response curves.


Subject(s)
Diarylheptanoids/isolation & purification , Diarylheptanoids/pharmacology , Dinoprostone/antagonists & inhibitors , Zingiberaceae/chemistry , Animals , Diarylheptanoids/chemistry , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Leukemia P388 , Mice , Nuclear Magnetic Resonance, Biomolecular , Rhizome/chemistry , Swiss 3T3 Cells
3.
Sports Med ; 39(12): 1033-54, 2009.
Article in English | MEDLINE | ID: mdl-19902984

ABSTRACT

Bovine colostrum (BC) is rich in immune, growth and antimicrobial factors, which promote tissue growth and the development of the digestive tract and immune function in neonatal calves. Although the value of BC to human adults is not well understood, supplementation with BC is becoming increasingly popular in trained athletes to promote exercise performance. The combined presence of insulin-like growth factors (IGF), transforming growth factors, immunoglobulins, cytokines, lactoferrin and lysozyme, in addition to hormones such as growth hormone, gonadotrophin-releasing hormone, luteinizing hormone-releasing hormone and glucocorticoids, would suggest that BC might improve immune function, gastrointestinal integrity and the neuroendocrine system, parameters that may be compromised as a result of intensive training. A review of studies investigating the influence of BC supplementation on exercise performance suggests that BC supplementation is most effective during periods of high-intensity training and recovery from high-intensity training, possibly as a result of increased plasma IGF-1, improved intramuscular buffering capacity, increases in lean body mass and increases in salivary IgA. However, there are contradicting data for most parameters that have been considered to date, suggesting that small improvements across a range of parameters might contribute to improved performance and recovery, although this cannot be concluded with certainty because the various doses and length of supplementation with BC in different studies prevent direct comparison of results. Future research on the influence of BC on sports performance will only be of value if the dose and length of supplementation of a well-defined BC product is standardized across studies, and the bioavailability of the active constituents in BC is determined.


Subject(s)
Athletic Performance/standards , Colostrum , Dietary Supplements , Animals , Cattle , Colostrum/immunology , Female , Immune System/drug effects , Pregnancy
4.
Nutr Res ; 28(4): 251-7, 2008 Apr.
Article in English | MEDLINE | ID: mdl-19083416

ABSTRACT

The health benefits of fruits have been recognized for some time, but only recently have their effects on the immune system been investigated. Kiwifruit contains vitamins, minerals, and phytochemicals that are known to be important for normal functioning of the immune system. In this work, the influence of feeding 2 ZESPRI GOLD Kiwifruit processed products (Tauranga, New Zealand) on immune function in mice was investigated. Using a model to demonstrate adaptive immune responses in the gut, mice were fed either ZESPRI GOLD Kiwifruit puree or ZESPRI GOLD Kiwifruit 40 degrees Brix Juice concentrate for 20 days, during which time they were immunized via the oral route with ovalbumin and subsequently given a suboptimal dose of the mucosal adjuvant cholera toxin. ZESPRI GOLD Kiwifruit puree enhanced the response to ovalbumin by significantly increasing the levels of total immunoglobulins and immunoglobulin G specific for ovalbumin and enhanced the antigen-specific proliferation of cells from the draining mesenteric lymph nodes compared with mice fed a 20% sugar control. These results indicate that ZESPRI GOLD Kiwifruit can modulate an antigen-specific immune response and suggest that ZESPRI GOLD Kiwifruit may represent a new type of functional food ingredient.


Subject(s)
Actinidia , Antibody Formation , Immunity, Mucosal , Lymph Nodes/cytology , Ovalbumin/immunology , Actinidia/chemistry , Actinidia/immunology , Administration, Oral , Analysis of Variance , Animals , Antibody Specificity , Cell Division , Cholera Toxin , Female , Immunoglobulin G/immunology , Immunoglobulins/immunology , Mice , Mice, Inbred C57BL , Random Allocation
5.
Nutr Res ; 28(9): 583-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-19083463

ABSTRACT

Dietary supplements of bovine lactoferrin are purported in consumer literature to enhance and support the immune system response through their antioxidant, antibacterial, and antiviral properties. Our aim was to investigate more fully the potential immune modulating properties and antioxidant activity of an oral supplementation of bovine lactoferrin in humans. Using an intraindividual repeated measure design, 8 healthy males aged 30 to 55 years, self-administered daily for 21 days, one capsule of placebo for 7 days, followed by 100 mg of lactoferrin for 7 days, followed by 200 mg of lactoferrin for 7 days. Peripheral blood lymphocyte subset counts, T-cell activation, natural killer (NK) cell cytotoxicity, serum cytokine levels (tumor necrosis factor [TNF]-alpha, interferon [IFN]-gamma, interleukin [IL]-2, IL-4, IL-6, and IL-10), and serum hydrophilic, lipophilic, and total antioxidant capacity were repeatedly measured before and after each progressive supplementation. Statistically significant increases were found between presupplementation levels and levels after 200 mg of supplementation in total T-cell activation (as measure by CD3(+)) (P < .001), helper T-cell activation (as measure by CD4(+)) (P < .001), cytotoxic T-cell activation (as measured by CD8(+)) (P < .001), and hydrophilic antioxidant capacity (P < .05). No significant changes were seen in the other parameters measured. These results support the proposal that oral supplements of bovine lactoferrin may be a useful adjunct toward modulation of immune activity, in particular T-cell activation and antioxidant status.


Subject(s)
Antioxidants/analysis , Immunity/drug effects , Lactoferrin/administration & dosage , Adult , Animals , Anti-Bacterial Agents/administration & dosage , Antiviral Agents/administration & dosage , Cattle , Cytokines/blood , Dietary Supplements , Humans , Lymphocyte Activation/drug effects , Lymphocyte Count , Male , Middle Aged , Placebos , T-Lymphocytes/immunology
6.
Molecules ; 10(10): 1279-85, 2005 Oct 31.
Article in English | MEDLINE | ID: mdl-18007520

ABSTRACT

Echinacea preparations are widely used herbal medicines for the prevention and treatment of colds and minor infections. There is little evidence for the individual components in Echinacea that contribute to immune regulatory activity. Activity of an ethanolic Echinacea extract and several constituents, including cichoric acid, have been examined using three in vitro measures of macrophage immune function - NF-kappaB, TNF- alpha and nitric oxide (NO). In cultured macrophages, all components except the monoene alkylamide (AA1) decreased lipopolysaccharide (LPS) stimulated NF-kappaB levels. 0.2 microg/ml cichoric acid and 2.0 microg/mL Echinacea Premium Liquid (EPL) and EPL alkylamide fraction (EPL AA) were found to significantly decrease TNF-alpha production under LPS stimulated conditions in macrophages. In macrophages, only the alkylamide mixture isolated from the ethanolic Echinacea extract decreased LPS stimulated NO production. In this study, the mixture of alkylamides in the Echinacea ethanolic liquid extract did not respond in the same manner in the assays as the individual alkylamides investigated. While cichoric acid has been shown to affect NF-kappaB, TNF-alpha and NO levels, it is unlikely to be relevant in the Echinacea alterations of the immune response in vivo due to its non- bioavailability - i.e. no demonstrated absorption across the intestinal barrier and no detectable levels in plasma. These results demonstrate that Echinacea is an effective modulator of macrophage immune responses in vitro.


Subject(s)
Echinacea , Macrophage Activation/drug effects , Plant Extracts/pharmacology , Animals , Cells, Cultured , Drug Evaluation, Preclinical , Echinacea/chemistry , Immunity, Cellular/drug effects , Immunologic Factors/pharmacology , Macrophages/drug effects , Macrophages/immunology , Mice , Models, Biological
SELECTION OF CITATIONS
SEARCH DETAIL
...